UF to test novel CAR-modified T-cell technique in clinical trial for glioblastoma
University of Florida researchers have received approval from the Food and Drug Administration to test an investigational new therapy in a first-in-human clinical trial for participants with primary glioblastoma, the most aggressive malignant brain tumor.